David Canter

Title: David Canter: Innovator in Genetic Mutation Detection

Introduction

David Canter is a prominent inventor based in San Diego, CA, known for his contributions to the field of genetic mutation detection. With a total of 5 patents to his name, Canter has made significant strides in developing methods that enhance the screening and identification of genetic polymorphisms.

Latest Patents

One of Canter's latest patents focuses on methods and apparatus for screening and detecting multiple genetic mutations. This innovative assay system analyzes patient samples containing genomic DNA to identify known genetic polymorphisms using a universal reporter strategy. In a preferred embodiment, the amplified DNA is localized at test sites on a microchip, followed by a series of hybridization reactions. This process screens for the presence of a single mutation among several mutations, allowing for the precise identification of specific mutations. Additionally, the assay may incorporate universal reporters, blockers, and discriminators to improve the screening and identification of known polymorphisms.

Career Highlights

Throughout his career, David Canter has worked with notable companies such as Nanogen, Inc. and Gamida for Life B.V. His experience in these organizations has contributed to his expertise in genetic research and innovation.

Collaborations

Canter has collaborated with several professionals in his field, including Ray R. Radtkey and Michael I. Nerenberg. These collaborations have further enriched his work and expanded the impact of his inventions.

Conclusion

David Canter's innovative work in genetic mutation detection showcases his dedication to advancing medical technology. His patents and collaborations reflect a commitment to improving genetic screening methods, ultimately benefiting the field of genetics and patient care.